Clinical trials
Completed trials in Luxembourg
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
102 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 8 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 11 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 9 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 102 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Luxembourg Institute of Health | 13 |
| Hoffmann-La Roche | 9 |
| Bayer | 6 |
| Centre Hospitalier du Luxembourg | 4 |
| Novo Nordisk A/S | 4 |
| AstraZeneca | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Pfizer | 3 |
| Bristol-Myers Squibb | 2 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 8 |
| Arthritis, Rheumatoid | 5 |
| Breast Neoplasms | 5 |
| COVID-19 | 5 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Diabetes Mellitus | 5 |
| Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Cardiovascular Diseases | 4 |
| Aortic Valve Disease | 3 |
Trials
Showing 51 to 75 of 102. Each trial links to its page on Pharma Observatory.
2 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.